News and updates

Media Releases

New Zealanders' views on human gamete and embryo research wanted

15 December 2006

New Zealanders’ views on allowing human gamete and embryo research and, if so, the conditions which should apply, are being sought by the Government’s advisory committee on assisted reproductive technology.

ACART, the Advisory Committee on Assisted Reproductive Technology, today published a discussion paper which will inform Government policy on this issue. Use of Gametes and Embryos in Human Reproductive Research: Determining Policy for New Zealand presents information from a variety of perspectives: scientific, ethical, cultural, legal and policy as well as seeking submissions to the Committee.

“New Zealanders have had limited opportunity to date to influence policy on gamete and embryo research” says Professor Sylvia Rumball, Chair of ACART.

“We expect that there will be many different views and ACART hopes to hear them all before it decides what advice it will give to the Minister of Health. I encourage all New Zealanders to take part in this discussion.”

Internationally, scientific developments involving the use of gametes and embryos in research are taking place. These developments further our understanding of normal growth and development. New Zealand researchers would like the opportunity to contribute to this work. However, the use of gametes and embryos for research raises ethical, cultural and spiritual issues, which must be considered. ACART will provide the Minister of Health with advice on the use of gametes and embryos in research following this consultation.

Submissions close on 2 March 2007.

Discussion document and background information

Download discussion document

Questions and answers on the use of gametes and embryos in human reproductive research

For further media information contact:

Chair, Advisory Committee on Assisted Reproductive Technology (ACART) Professor Sylvia Rumball
Phone: 06 350 5249 or 021 535 001

Media advisor: Ministry of Health
Rebecca Walsh
Phone: (04) 496 2115 or (021) 277 5411.